Salute e Benessere

AC Immune to Present at the Jefferies 2024 London Healthcare Conference

AC Immune to Present at the Jefferies 2024 London Healthcare ConferenceLausanne, Switzerland, November 13, 2024– AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Company Management will participate in a fireside chat and one-on-one investor meetings during the Jefferies 2024 London Healthcare Conference, taking place in-person in London on November 19-21, 2024.The fireside chat...
Nasdaq GlobeNewswire
13/11/2024

Major shareholder announcement

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.Per November 11, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,180,630 shares, corresponding to 4.94% (previously 5.02%) of the total share capital attached to shares. The combined total of share...
Nasdaq GlobeNewswire
13/11/2024

BioNTech to Acquire Biotheus to Boost Oncology Strategy

Acquisition to support the global execution of BioNTech's oncology strategy and provide full global rights to BNT327/PM8002, an investigational PD-L1 x VEGF-A bispecific antibody, with potential to replace current checkpoint inhibitor standard of care treatments for solid tumorsWith the acquisition of Biotheus, BioNTech aims to further strengthen its capabilities to develop, manufacture and commercialize next-generation bispecific antibodies and novel treatment combinationsBioNTech...
Nasdaq GlobeNewswire
13/11/2024

Global Dermatological Drugs Market to Cross USD 31 Billion by 2030 |…

Key Takeaways from the Dermatological Drugs Market Report Key Takeaways from the Dermatological Drugs Market Report To read more about the latest highlights related to the dermatological drugs market, get a snapshot of the key highlights entailed in the Global Dermatological Drugs Market Report Dermatological Drugs Overview Dermatological drugs are a category of medications used to treat a wide range of skin conditions, including acne, eczema, psoriasis, fungal infections, and dermatitis...
PR Newswire
13/11/2024

EAACI to Launch World Anaphylaxis Awareness Day on 21 November at FAAM-EUROBAT…

ATHENS, Greece, Nov.13, 2024(GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical Immunology (EAACI) is proud to announce the inaugural World Anaphylaxis Awareness Dayon 21 November 2024. This landmark initiative, held on the opening day of FAAM-EUROBAT 2024 in Athens, Greece, seeks to raise awareness and promote essential steps in preventing and managing anaphylaxis, a severe, potentially life-threatening allergic reaction.Anaphylaxis affects approximately 1-2% of...
Nasdaq GlobeNewswire
13/11/2024

Revolutionizing Heart Health: Frontier X Plus Gains FDA Clearance

"We have seen cardiac arrhythmias develop in individuals of all ages, and the incidence is significantly higher for individuals who are both active and have cardiac health risk factors. The percentage of population that falls in the confluence of these categories is continuously rising. Since the FX+ is able to capture ECGs during all kinds of motion and activity, we think this will be a game changer and significantly improve the early detection of cardiovascular disease," said…
PR Newswire
13/11/2024

Oculis to Present at the Stifel 2024 Healthcare Conference

Sylvia Cheung, Chief Financial Officer of Oculis, will participate in a fireside chat on November 18, 2024 at 3:35 pm ET. A live webcast of the fireside chat will be available here . The Company will be available for one-on-one meetings during the conference. Interested investors should contact their Stifel representative to request meetings. A link to access the fireside chat, when available, will be posted to Oculis website on the Events & Presentation page under the Investors...
Nasdaq GlobeNewswire
13/11/2024

ImageBiopsy Lab launches IB Lab FROG: AI-powered Foot Measurements for…

IB Lab FROG addresses these challenges by covering the five most common use cases in foot assessment on dorsal-plantar and lateral X-ray images. Its automated measurements are based on radiological and orthopedic standards, significantly enhancing consistency, standardization, and precision in foot diagnostics. IB Lab FROG addresses these challenges by covering the five most common use cases in foot assessment on dorsal-plantar and lateral X-ray images. Its automated measurements are based on...
PR Newswire
13/11/2024

mediaire transforms radiology with AI, securing a European €12 million…

"Our AI solutions are not a futuristic dream. We have already created a reality that is helping doctors make better decisions and giving patients faster answers," says Dr. Andreas Lemke, CEO, and co-founder of mediaire. "We are seeing the impact on thousands of radiologists every day in hundreds of hospitals and radiology practices across Europe that are utilizing our AI solutions. With this investment, we will be able to scale these benefits to even more healthcare…
PR Newswire
13/11/2024

Royal Reception for KFSHRC Surgeons who performed the World 1st Full Robotic…

RIYADH, Saudi Arabia, Nov.13, 2024(GLOBE NEWSWIRE) -- His Royal Highness Crown Prince and Prime Minister Mohammed bin Salman received the Saudi medical team that performed the world's first fully robotic heart transplant at his office in Riyadh on Wednesday.The medical team from King Faisal Specialist Hospital & Research Centre (KFSHRC) of Riyadh had successfully performed the world's first heart transplant using a robot on a 16-year-old patient suffering from end-stage heart...
Nasdaq GlobeNewswire
13/11/2024

Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners

The Clarivate Healthcare Business Insights Revenue Cycle Awards honor healthcare organizations demonstrating excellence in KPIs critical to fiscal health. This year's winners achieved top decile performance across diverse metrics and implemented forward-looking initiatives to address key challenges in the healthcare landscape. The Clarivate Healthcare Business Insights Revenue Cycle Awards honor healthcare organizations demonstrating excellence in KPIs critical to fiscal health. This year's...
PR Newswire
13/11/2024

Photocure ASA: Results for the third quarter of 2024

Photocure reported total group revenues of NOK 120.2 million in the third quarter of 2024 (NOK 107.5 million), and EBITDA* of NOK 5.0 million (NOK 3.3 million), driven by revenue growth in North America and Europe. Hexvix/Cysview revenues ended at NOK 120.1 million in the quarter (Q3 2023: NOK 107.3 million). The EBIT was NOK -2.2 million (NOK -3.9 million) and the cash balance at the end of the period was NOK 291.1 million. Photocure reported total group revenues ofNOK 120.2 millionin the...
PR Newswire
13/11/2024

SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes…

The case study followed the progress of an 8-year-old girl with severe AD over a period of 6 months, measuring improvements in skin barrier integrity using Nevisense. The results were extremely positive, with the patient's SCORAD improving from 96 to 37 by the end of the treatment period. The correlation between SCORAD and Nevisense output (EIS) was significant, highlighting the potential for Nevisense to be used as a non-invasive tool to evaluate treatment efficacy in AD patients. The case...
PR Newswire
13/11/2024

Musim Mas Achieves a Top 5 Rank in the Global Child Forum Benchmark 2024

These achievements showcase Musim Mas' proactive integration of children's rights into its business strategies. The Group has aligned its approach with the United Nations Convention on the Rights of the Child. Musim Mas's Sustainability Policy and active participation in the Roundtable on Sustainable Palm Oil (RSPO) further exemplify these commitments. These achievements showcase Musim Mas' proactive integration of children's rights into its business strategies. The Group has aligned its...
PR Newswire
13/11/2024

BerGenBio Third Quarter Results 2024

BGBC016 1L NSCLC STK11m Study BGBC016 1L NSCLC STK11m Study 1L STK11m NSCLC: a Widely Recognized Risk Factor Tilvestamab Martin Olin, Chief Executive Officer of BerGenBio stated: "BerGenBio continues to progress its focused strategy to develop its lead AXL inhibitor bemcentinib in first-line NSCLC patients with mutations in the STK11 gene which, we believe, represent a significant commercial opportunity. The on-going BGBC016 study in this population continues to progress and...
PR Newswire
13/11/2024

IM Cannabis Closes Non-Brokered Private Placement led by Management and…

Each Unit was sold at a price ofC$2.88per Unit, calculated on the basis of the deemed price per Share equal to the 10-day volume weighted average price of the Shares on the Exchange ending on the trading day precedingOctober 3, 2024, and consisted of one Share and one Warrant. Each Warrant entitles the holder thereof to acquire one Warrant Share at a price ofC$4.32per Warrant Share, calculated as a 50% premium to the Offering Price, at any time prior to5:00 pm(Toronto...
PR Newswire
12/11/2024

Sanofi/Regeneron Pharmaceuticals' DUPIXENT Approval Marks a Significant Shift in…

As per DelveInsight analysis, the diagnosed prevalent population of COPD in the 7MM was around 44 million in 2023. These cases of COPD in the 7MM are expected to increase at a significant CAGR of 1.4% throughout the study period (2020–2034). As per DelveInsight analysis, the diagnosed prevalent population of COPD in the 7MM was around44 millionin 2023. These cases of COPD in the 7MM are expected to increase at a significant CAGR of1.4%throughout the study period (2020–2034). As per...
PR Newswire
12/11/2024

Notice to extraordinary general meeting in Scibase Holding AB (publ)

A shareholder who wishes to participate at the extraordinary general meeting must: A shareholder who wishes to participate at the extraordinary general meeting must: Nominee-registered shares Shareholders whose shares are held in the name of a nominee must, in order to be able to participate at the general meeting and exercise their voting right, temporarily re-register the shares in their...
PR Newswire
12/11/2024

The Shaw Prize Award Presentation Ceremony 2024: 21 Years of Celebrating…

The 2024 Shaw Laureates, Professor Shrinivas Kulkarni, Dr Swee Lay Thein, Professor Stuart Orkin, and Professor Peter Sarnak, were then presented with their awards by Professor Reinhard Genzel, Chair of the Board of Adjudicators. The 2024 Shaw Laureates, ProfessorShrinivas Kulkarni, DrSwee Lay Thein, ProfessorStuart Orkin, and ProfessorPeter Sarnak, were then presented with their awards by ProfessorReinhard Genzel, Chair of the Board of Adjudicators. During his acceptance...
PR Newswire
12/11/2024

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives…

Bagsværd, Denmark, 12 November 2024— This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and...
Nasdaq GlobeNewswire
12/11/2024

Glaucoma Therapeutics Market Analysis by Size, Share, and Growth | Market Value…

The report from The Insight Partners provides several stakeholders—including manufacturers, physicians and other end users—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. The report from The Insight Partners provides several stakeholders—including manufacturers, physicians and other end users—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. Download...
PR Newswire
12/11/2024

Botulinum Toxin Market Analysis by Size, Share, and Growth | Market Value 19.03…

Download Sample Pages of Research analysis: https://www.theinsightpartners.com/sample/TIPRE00011895/ Download Sample Pages of Research analysis:https://www.theinsightpartners.com/sample/TIPRE00011895/ Regional analysis – Overview of Report Findings Read full market research report, " Botulinum Toxin Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Botulinum Toxin A and Botulinum...
PR Newswire
12/11/2024

Artificial Intelligence in Drug Discovery Market to Hit USD 6.89 Billion by 2029…

Browse in-depth TOC on "Artificial Intelligence in Drug Discovery Market" Browse in-depth TOC on "Artificial Intelligence in Drug Discovery Market" 270 - Tables 50 - Figures 350 - Pages Based on therapeutic area,the artificial intelligence (AI) in drug discovery market is segmented into oncology, infectious diseases, neurology, metabolic diseases, cardiovascular diseases, immunology, mental health, and others (respiratory diseases, nephrology, dermatological diseases,...
PR Newswire
12/11/2024

Nasal Drug Delivery Technology Market Breakthrough in Patient Care, Projected…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=204829 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=204829 202 – Pages 126 – Tables 37 – Figures Scope Of The Report Nasal Drug Delivery Technology Market Overview 1.Market Definition and Scope The Nasal Drug Delivery Technology Market encompasses a range of drug delivery systems that administer medications through the nasal cavity...
PR Newswire
12/11/2024
Altri  Comunicati